FindTrial
Sign In

The precise stratification of fertility-sparing treatment for young patients with early-stage cervical cancer

The precise stratification of fertility-sparing treatment for young patients with early-stage cervical cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-17012828
Enrollment
Unknown
Registered
2017-09-28
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

The women for fertility-sparing treatment:fertility-sparing treatment

Sponsors

Anhui Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: All women for fertility-sparing treatment should meet the following standards:younger than 40 years old with strong desire for fertility preservation; IA1 ~ IIA stage; pathological types: squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma; wihout lymph node metastasis in MRI or PET-CT images; without obvious infertility factors; fully informed consent; with precise preoperative pathological diagnosis.

Exclusion criteria

Exclusion criteria: older than 40 years old ;beyond the IIA stage; wih lymph node metastasis in MRI or PET-CT images; with infertility factors; not fully informed consent; without precise preoperative pathological diagnosis.

Design outcomes

Primary

MeasureTime frame
successfully fertility-sparing cervical cancer patients;—

Countries

China

Contacts

Public ContactYing Zhou

Anhui Provincial Hospital

caddie1234@gmail.com+86 13865901025

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026